Rosavin

CAS No. 84954-92-7

Rosavin( Rosavin | )

Catalog No. M19178 CAS No. 84954-92-7

Rosavin has antidepressant and anxiolytic actions, helps balance all the neurotransmitters.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 49 In Stock
5MG 76 In Stock
10MG 108 In Stock
25MG 253 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Rosavin
  • Note
    Research use only, not for human use.
  • Brief Description
    Rosavin has antidepressant and anxiolytic actions, helps balance all the neurotransmitters.
  • Description
    Rosavin is a bioactive antidepressant component isolated from Rhodiola rosea L.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Rosavin |
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    CYP3A4
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    84954-92-7
  • Formula Weight
    428.43
  • Molecular Formula
    C20H28O10
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (233.41 mM)
  • SMILES
    O1[C@H]([C@@H]([C@H]([C@@H]([C@H]1CO[C@@H]1OC[C@@H]([C@@H]([C@H]1O)O)O)O)O)O)OC/C=C/c1ccccc1
  • Chemical Name
    (2R,3R,4S,5S,6R)-2-(cinnamyloxy)-6-((((2S,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3,4,5-triol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Grech-Baran M1,et al. Biotechnol Lett. 2014 Mar;36(3):649-56.
molnova catalog
related products
  • NSC 625987

    NSC 625987 is a potent, selective CDK4 inhibitor with IC50 of 0.2 uM, displays >500-fold selectivity over CDK2 (IC50 >100 uM for cdc2/cyclin A, cdk2/cyclin A and cdk2/cyclin E).

  • THZ 531

    THZ 531 (THZ531) is a first-in-class, selective CDK12 and CDK13 covalent inhibitor with IC50 of 158 nM and 69 nM, respectively.

  • LY2857785

    LY2857785 is a potenrt, reversible and ATP-competitive CDK9 inhibitor with IC50 of 11 nM, also inhibits CDK8 (IC50=16 nM) and weakly inhibits CSK7 (IC50=246 nM).